RTW Investments L.P. — Full Portfolio

Apogee Therapeutics develops engineered antibody therapies to treat inflammatory and immune diseases with reduced injection frequency compared to existing treatments.

BiotechHealthtechMedical Devices

MHMichael Henderson(Chief Executive Officer and Director)in

Co-investorsACAccess BiotechnologyRARA CapitalBLBlackstone Life SciencesPEPerceptive Xontogeny VentureVEVenrock Healthcare Capital Partners

Aquestive Therapeutics develops and commercializes oral film drug formulations and other novel delivery systems for treatments in neurology, psychiatry, and emergency care, operating manufacturing facilities in Indiana that produce both licensed pharmaceutical products and proprietary candidates for regulated markets including the U.S., EU, and Australia.

BiotechWarren, US

KJKeith J Kendall(Chief Executive Officer)inA. Mark Shobel(Chief Operating Officer)Theresa Wood(Vice President, Human Resources)inPeter Boyd(Vice President, Value Delivery)DBDaniel Barber(Vice President, Business and Product Development)inJTJohn T Maxwell(Chief Financial Officer, Treasurer, Secretary)in

Co-investorsOAOaktree

Beta Bionics develops the iLet Bionic Pancreas System, an insulin delivery device for people with type 1 diabetes aged 6 and older that requires a physician's prescription.

Digital HealthHealthtechMedical DevicesIrvine, US

Edward Damiano(Executive Officer, Director)Sean Saint(President, Chief Executive Officer and Director)inSFStephen Feider(Chief Financial Officer)inMike Mensinger(Chief Product Officer)inSRSteven Russell(Chief Medical Officer)inMHMark Hopman(Chief Commercial Officer)in

Co-investorsOMOmega FundsSOSoleus Capital

Kalaris Therapeutics is a clinical-stage biopharmaceutical company developing treatments for prevalent retinal diseases such as wet AMD, diabetic eye disease, and retinal vein occlusion.

BiotechHealthtechBerkeley Heights, US

Srinivas Akkaraju(Director & Co-founder)MDMike Dybbs(Director & Co-founder)inNapoleone Ferrara(Director & Co-Founder)Andrew Oxtoby(CEO & Director)inMatthew Feinsod(CMO)Liisa Bayko(CFO)

Co-investorsSASamsara BioCapitalINInvus

Kyverna is a clinical-stage biopharmaceutical company developing CAR T-cell therapies to treat autoimmune diseases through B cell depletion and immune system reset.

BiotechEmeryville, US

WBWarner Biddle(Chief Executive Officer)inBrian Kotzin(Director)Ian Clark(Director)Ryan Jones(Executive Officer)Karen Walker(Executive Officer)PMPeter Maag(Executive Officer, Director)in

Co-investorsBABain Capital Life SciencesVIVida VenturesWEWestlake Village BioPartnersGIGilead SciencesKLKleiner PerkinsOXOxford Finance LLC+1 more

Neurogene develops gene therapy treatments for rare neurological diseases.

BiotechDeep TechDigital HealthLongevityMedical DevicesNew York, US

RMRachel McMinn(Founder and Chief Executive Officer)inRMRachel McMinn, Ph.D.(Founder and Chief Executive Officer)

BoardCory Freedland(Director)inStephen Biggar(Director)

Co-investorsECEcoR1 CapitalSASamsara BioCapitalCACasdin CapitalREREDMILEWIWilliam Blair

Pyxis Oncology is a clinical-stage biotech company developing antibody-drug conjugates for solid tumors, with its lead candidate targeting a fibronectin variant found in tumor tissue but not healthy tissue.

HealthtechBoston, US

Thomas Civik(Interim Chief Executive Officer, Director)

BoardDSDavid Steinberg(Executive Officer, Director)inCWChristoph Westphal(Director)GVGeeta Vemuri(Director)inJak Knowles(Director)John Flavin(Director)

Co-investorsAGAgent CapitalLOLongwood FundRARA Capital

Stoke Therapeutics develops RNA-based antisense oligonucleotides to treat severe genetic diseases by restoring protein expression through its TANGO platform, with a lead program in late-stage clinical development for Dravet syndrome and additional programs targeting other genetic disorders of the central nervous system and eye.

BiotechBedford, US

Adrian Krainer(Executive Officer, Director, Promoter)Isabel Aznarez(Executive Officer, Director, Promoter)inHNHuw Nash(Executive Officer)inIFIan F. Smith(Chief Executive Officer and Director)Jason Hoitt(Chief Patient Officer)inThomas E. Leggett(Chief Financial Officer)

Co-investorsSCScion Life Sciences5A5AM Ventures

Tarsus is a biopharmaceutical company focused on developing and delivering medicines that target the root cause of serious diseases with high unmet need, including eye conditions.

BiotechHealthtechMedical Devices

BABobak Azamian, MD, PhD(Founder)inBABobak Azamian(President and Chief Executive Officer)inJeffrey Farrow(Chief Financial Officer and Chief Strategy Officer)Seshadri Neervannan(Chief Operating Officer)AMAziz Mottiwala(Chief Commercial Officer)inDWDianne Whitfield(Chief Human Resources Officer)in

Co-investorsAPAPERTURE Venture PartnersFLFlying L PartnersFRFrazier Life SciencesVIVisionary VenturesVIVivo CapitalBABain Capital Life Sciences+1 more

Offers soft tissue repair solutions combining naturally sourced tissue with polymer; lead product OviTex for hernia repair (NASDAQ: TELA), based in Malvern, PA.

BiotechMalvern, US

Antony Koblish(Founder)inFrancis Conway(Executive Officer)MPMaarten Persenaire(Executive Officer)Christine Arasin(Executive Officer)

BoardKRKevin Rakin(Director)inAshley Freidman(Director)

Co-investorsCHCheckmate Capital Group LLCESEssex Woodlands Healthcare PartnersHIHighCape CapitalOROrbiMedSISignet Healthcare Partners131315 Capital

Santa Ana Bio is a biotech company developing engineered antibody therapeutics that target the immune pathways and cells driving autoimmune and inflammatory diseases.

AI & Machine LearningBiotechHealthtechAlameda, US

PEPeter Emtage(Founder & CEO)inAlexander Rudensky(Scientific Founder)Richard Flavell(Scientific Founder)GLGraham Lord(Scientific Founder)inASAnsuman Satpathy(Scientific Founder)inNYNewman Yeilding(Chief Medical Officer)in

Co-investorsVEVersant VenturesACAccess BiotechnologyANAndreessen HorowitzGVGV (Google Ventures)TPTPG

Rocket Pharmaceuticals develops gene therapies to treat patients with rare genetic diseases, focusing on cardiovascular and hematologic disorders.

BiotechDigital HealthMedical Devices

GSGaurav Shah(Co-founder & Chief Executive Officer)in

Board seatRoderick WongNYNaveen Yalamanchi· per SEC Form D · $30.1M raise · filed May 2017

Co-investorsAVAvoro Capital AdvisorsBRBroadview VenturesCICivilization Ventures Management, Llc

Alesta Therapeutics develops therapies for rare diseases, with research focused on genetic diseases and oncology.

BiotechHealthtech

IGIlan Ganot(CEO)inBMBenit Maru(CMO)MVMatthias Van Woensel(CSO)in

Co-investorsDRDroia VenturesFRFrazier Life SciencesNONovartis Venture FundFRFrazier Healthcare PartnersMPMPM BioImpactTHThuja Capital

Basking Biosciences develops therapeutics for thrombosis, vascular biology, and ischemic disease.

BiotechDigital HealthHealthtechMedical DevicesCary, US

SNShahid Nimjee(Co-founder, Chief Scientific Officer and Stroke Clinical Lead)inBruce Sullenger(Co-founder)JOJulia Owens(Executive Officer, Director, Promoter)inRSRichard Shea(Executive Officer, Director, Promoter)in

BoardHannah Chang(Director)AAAiden Aceves(Director)in

Co-investorsARARCH Venture PartnersINInsight PartnersBRBroadview VenturesSOSolas BioVenturesRERev1 Ventures

DealForma provides a data platform and analyst support for biopharma business development teams to research partnerships, deals, funding trends, and therapeutic areas.

BiotechData & InfrastructureHealthtechSaaS

Chris

Co-investorsTITinySeedALAlgerRARA CapitalREREDMILESOSofinnova Ventures

Encoded develops gene therapies for neurological disorders through an integrated platform approach.

Biotech

STStephanie Tagliatela(Founder)in

Co-investorsARARCH Venture PartnersBIBioBritGVGV (Google Ventures)ILIllumina VenturesMEMenlo VenturesSOSoftBank Vision Fund+1 more

LENZ Therapeutics is a pharmaceutical company developing and commercializing VIZZ™, an FDA-approved aceclidine-based eye drop for treating presbyopia, a vision condition affecting over 128 million people in the US.

BiotechHealthtechMedical DevicesSan Diego, US

JMJames McCollum(Co-founder, Board Member)ESEef SchimmelpenninkinESEvert Schimmelpennink(President and CEO)

Co-investorsALAlpha Wave GlobalRARA CapitalRARaptor GroupSESectoral Asset ManagementVEVersant Ventures

Lycia Therapeutics is a biotechnology company developing LYTAC (Lysosomal Targeting Chimera) therapeutics that bind disease-causing extracellular and cell-surface proteins and route them into the cell's lysosome for degradation.

BiotechHealthtechSouth San Francisco, US

AWAetna Wun Trombley(President and CEO)inABAmy Bachrodt(Chief Financial Officer)inCLChin Lee(Chief Medical Officer)inSSSteve Staben(Chief Scientific Officer)inSTSofia Touami(Chief Business Officer)inKFKaren Flick(General Counsel)in

Co-investorsREREDMILEVEVersant VenturesBABAM ElevateFRFranklin TempletonHBHBM Healthcare InvestmentsINInvus+4 more

Magnolia Medical develops diagnostic devices to reduce blood culture contamination and false-positive sepsis test results for hospitals and healthcare systems.

HardwareHealthtechMedical DevicesSeattle, US

Gregory J Bullington(Executive Officer, Director)RPRichard Patton(Co-founder)

BoardPaul Meister(Director)

Co-investorsEVEvidity Health CapitalLALauder PartnersRHRhapsody Venture PartnersVIVivo CapitalHEHealthQuest CapitalJAJanus Henderson Investors+2 more

Milestone Pharmaceuticals is a life sciences company that develops therapies for patients with cardiovascular and other diseases.

BiotechDigital HealthHealthtechMedical DevicesMontreal, US

Ela Borenstein(Director)Francis Plat(Executive Officer)Yves Rosconi(Director)Scott Weiner(Director)Martin Maguire(Executive Officer)Philippe Douville(Executive Officer, Director)

Co-investorsPAPappas CapitalFOForbion

Neurogastrx is a biopharmaceutical company developing therapies for patients with gastrointestinal disorders.

BiotechHealthtechWoburn, US

CDCyril De Colle(Founder)inCDCYRIL DE COLLE(Executive Officer, Director)inJAMES DETORE(Executive Officer)JOJAMES O'MARA(Executive Officer, Director)inPAUL ROGERS(Executive Officer)in

BoardDADAVID ALLISON(Director)in

Co-investors5A5AM VenturesOROrbiMedSASamsara BioCapitalVEvenBio PartnersVIVivo CapitalVEvenBio Global Strategic+1 more

Oricell Therapeutics (原启生物) is a clinical-stage biopharmaceutical company developing cell therapies, including CAR-T products targeting GPRC5D for relapsed/refractory multiple myeloma and GPC3 for advanced liver cancer.

BiotechDeep TechHealthtechShanghai, CN

HYHelen Yang(Founder)in

Co-investorsQIQiming Venture PartnersVIVivo CapitalQUQuan Capital

Serapha Bio is a biotechnology company.

Biotech

Co-investorsRARA CapitalVIVivo Capital

HealthtechIrvine, US

Kenny Chang(Executive Officer)W. Ronald Redmond(Director)Vijay Dhaka(Executive Officer)Philong Pham(Executive Officer, Director)Hongsheng Tong(Executive Officer, Director)

Co-investorsBLBlackRockENEndeavour VisionMVMVM Life Science PartnersSOSoleus CapitalVEvenBio Global StrategicVIVivo Capital

Windward delivers AI-powered operational intelligence for maritime security and commercial applications, fusing behavioral analytics and multi-sensor data to detect threats and opportunities.

AI & Machine LearningData & InfrastructureDefense TechTel Aviv

Amiad Daniel(Executive Officer, Director)MPMatan Peled(Director)in

BoardDov Gatmon(Director)Patrick Poon(Director)ESEden Shochat(Director)inTHThompson Hutton(Director)in

Co-investorsALAlephFTFTV CapitalTHThompson Hutton, LLCJAJanus Henderson InvestorsPIPivotal Life SciencesQIQiming Venture Partners+3 more

Windward Bio is a clinical-stage biotechnology company developing long-acting monoclonal and bispecific antibodies for serious immunological conditions such as asthma, COPD, and dermatological diseases.

BiotechHealthtech

Co-investorsOROrbiMedQUQuan CapitalRARA CapitalSASanofi VenturesSRSR One Capital ManagementJAJanus Henderson Investors+3 more